April 12, 2023
Kasper Bødker Mejlvang Tapped as New Novo Japan Chief Novo Nordisk rang up record revenue in Japan in 2022 with sales surging 9.5% year on year to 119.6 billion yen, spurred primarily by its GLP-1 agents Ozempic (semaglutide injection) and...read more